Does Aspartame Trigger Migraine? No, Says FDA
There is an ongoing controversy as to whether aspartame is responsible for causing headaches in people who ingest it. The FDA calls aspartame the most researched food additive ever approved. Read more
What Medications Interact With Viagra?
Like with any other medication there are always drug interactions that have to be taken into consideration. The same holds true with Viagra which is why the FDA approved it through prescription only. Read more
FDA Requests Boxed Warnings On Older Class Of Antipsychotic Drugs
FDA exercised its new authority under the Food and Drug Administration Amendments Act of 2007 (FDAAA) to require manufacturers of “conventional” antipsychotic drugs to make safety-related changes to prescribing information, or labeling Read more
FDA Announces New Labeling Changes For Regranex
FDA announced the addition of a boxed warning to the label of Regranex Gel 0.01% (becaplermin) to address the increased risk of cancer mortality in patients who use 3 or more tubes of the product. Regranex is a topical cream indicated for the treatment of leg and foot ulcers that are not healing in diabetic patients. Read more
FDA Approves Carbinoxamine Maleate Tablet
Boca Pharmacal announced that the U.S. Food and Drug Administration has granted final approval for the Company’s Abbreviated New Drug Application (ANDA) to market its generic version of Pamlab’s Palgic 4mg Tablet (Carbinoxamine Maleate 4 mg Tablet). The Company plans to launch its product immediately. Read more
FDA Warns Consumers Not To Eat Raw Red Tomatoes
FDA is alerting consumers in New Mexico and Texas that a salmonellosis outbreak appears to be linked to consumption of certain types of raw red tomatoes and products containing raw red tomatoes. The bacteria causing the illnesses are Salmonella serotype Saintpaul, an uncommon type of Salmonella. Read more
FDA Warns of Possible Child Cancer, Arthritis Drug Link
This morning FDA released and Early Communication about looking into Arthritis drugs and child cancer possible link. FDA says it’s an ongoing safety review of Tumor Necrosis Factor (TNF) Blockers that are marketed as Remicade, Enbrel, Humira, and Cimzia. Read more
International Pharmaceuticals Recalls Dietary Supplements
International Pharmaceuticals, Ltd., P.O. Box 5165, Bradford, MA 01835, announced today that it is conducting a voluntary recall of all the company’s supplement product sold under the brand name of Viril-Ity-Power (VIP) Tabs, 560mg/serving. Read more
FDA Advises To Switch To HFA-Propelled Albuterol Inhalers
FDA today issued a public health advisory to alert patients, caregivers and health care professionals to switch to hydrofluoroalkane (HFA)-propelled albuterol inhalers because chlorofluorocarbon (CFC)-propelled inhalers will not be available in the United States after Dec. 31, 2008. Read more
FDA Investigating Pfizer’s Anti-Smoking Drug Chantix
FDA is no investigating Pfizer’s anti-smoking drug Chantix after last week’s report about serious adverse side effects. Read more